Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Vachon

Showing results (211-220 of 408) with videos related to

Pageof 41
Sort By:
Blood Cancer Journal|March 18, 2020
The CCND1 c.870G risk allele is enriched in individuals of African ancestry with plasma cell dyscrasiasLinda B Baughn, Zhuo Li, Kathryn Pearce, et al.
Cancers|April 3, 2021
Genetic Predictors of Chemotherapy-Induced Peripheral Neuropathy from Paclitaxel, Carboplatin and Oxaliplatin: NCCTG/Alliance N08C1, N08CA and N08CB StudyAraba A Adjei, Camden L Lopez, Daniel J Schaid, et al.
Journal of the National Cancer Institute|March 26, 2026
Performance of clinical breast cancer risk prediction models versus a mammography-based artificial intelligence risk modelMedha Kaul, Christopher G Scott, Alena Wadzinske, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|March 21, 2007
A comprehensive examination of CYP19 variation and breast densityJanet E Olson, Cynthia X Ma, Linda L Pelleymounter, et al.
Cancers|February 13, 2021
Genetic Variations and Health-Related Quality of Life (HRQOL): A Genome-Wide Study ApproachAraba A Adjei, Camden L Lopez, Daniel J Schaid, et al.
Breast Cancer Research and Treatment|February 6, 2016
Natural history of age-related lobular involution and impact on breast cancer riskDerek C Radisky, Daniel W Visscher, Ryan D Frank, et al.
Cancer Prevention Research (Philadelphia, Pa.)|July 29, 2020
Breast Cancer Risk and Use of Nonsteroidal Anti-inflammatory Agents After a Benign Breast BiopsyMark E Sherman, Robert A Vierkant, Suneetha Kaggal, et al.
Breast Cancer Research and Treatment|September 28, 2006
A comprehensive examination of CYP19 variation and risk of breast cancer using two haplotype-tagging approachesJanet E Olson, James N Ingle, Cynthia X Ma, et al.
Leukemia|September 12, 2018
Risk of MGUS in relatives of multiple myeloma cases by clinical and tumor characteristicsAlyssa I Clay-Gilmour, Shaji Kumar, S Vincent Rajkumar, et al.
Breast Cancer Research and Treatment|June 8, 2010
Aromatase immunoreactivity is increased in mammographically dense regions of the breastCeline M Vachon, Hironobu Sasano, Karthik Ghosh, et al.
Pageof 41

Showing results (211-220 of 408) with videos related to

Sort By:
Pageof 41
Blood Cancer Journal|March 18, 2020
The CCND1 c.870G risk allele is enriched in individuals of African ancestry with plasma cell dyscrasiasLinda B Baughn, Zhuo Li, Kathryn Pearce, et al.
Cancers|April 3, 2021
Genetic Predictors of Chemotherapy-Induced Peripheral Neuropathy from Paclitaxel, Carboplatin and Oxaliplatin: NCCTG/Alliance N08C1, N08CA and N08CB StudyAraba A Adjei, Camden L Lopez, Daniel J Schaid, et al.
Journal of the National Cancer Institute|March 26, 2026
Performance of clinical breast cancer risk prediction models versus a mammography-based artificial intelligence risk modelMedha Kaul, Christopher G Scott, Alena Wadzinske, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|March 21, 2007
A comprehensive examination of CYP19 variation and breast densityJanet E Olson, Cynthia X Ma, Linda L Pelleymounter, et al.
Cancers|February 13, 2021
Genetic Variations and Health-Related Quality of Life (HRQOL): A Genome-Wide Study ApproachAraba A Adjei, Camden L Lopez, Daniel J Schaid, et al.
Breast Cancer Research and Treatment|February 6, 2016
Natural history of age-related lobular involution and impact on breast cancer riskDerek C Radisky, Daniel W Visscher, Ryan D Frank, et al.
Cancer Prevention Research (Philadelphia, Pa.)|July 29, 2020
Breast Cancer Risk and Use of Nonsteroidal Anti-inflammatory Agents After a Benign Breast BiopsyMark E Sherman, Robert A Vierkant, Suneetha Kaggal, et al.
Breast Cancer Research and Treatment|September 28, 2006
A comprehensive examination of CYP19 variation and risk of breast cancer using two haplotype-tagging approachesJanet E Olson, James N Ingle, Cynthia X Ma, et al.
Leukemia|September 12, 2018
Risk of MGUS in relatives of multiple myeloma cases by clinical and tumor characteristicsAlyssa I Clay-Gilmour, Shaji Kumar, S Vincent Rajkumar, et al.
Breast Cancer Research and Treatment|June 8, 2010
Aromatase immunoreactivity is increased in mammographically dense regions of the breastCeline M Vachon, Hironobu Sasano, Karthik Ghosh, et al.
Pageof 41